Current data suggest upregulation of IL-10 (30–35) and IL-22 as part of a hypothermia-associated cytokine profile counteracting overt pathological inflammation and strengthening biological barriers during severe systemic inflammation and infection. The gene discussed is IL22; the disease is infection.